Literature DB >> 1574251

Measurement of bromodeoxyuridine labeling index, Ki-67 score and Ag-NOR count in breast carcinomas. Comparison with DNA ploidy.

K Sasaki1, K Matsumura, T Murakami, T Tsuji.   

Abstract

Nuclear DNA content and three cell proliferation markers, the bromodeoxyuridine (BrdUrd) labeling index, Ki-67 score and Ag-nucleolar organizer region (Ag-NOR) counts, were measured in 21 cases of breast carcinoma, and then relationships among them were investigated. The BrdUrd labeling indices and Ki-67 scores were strongly correlated with one another (r = 0.90, p less than 0.001). They were also slightly correlated with the Ag-NOR counts (p less than 0.05). Although growth activity varied greatly from case to case, even within the same histologic grade in breast carcinoma, high histologic grade carcinomas were frequently associated with high values of both the BrdUrd labeling index and Ki-67 score, as compared with low histologic grade ones. The DNA ploidy level (DNA index) was independent of these cell proliferation markers. In the present series, 17 of 21 cases (81%) were aneuploid. All cases without DNA aneuploidy fell into a group of low histologic grade, while 7 of 11 low grade tumors were aneuploid. All three cell proliferation markers were low in 2 of the 4 cases without DNA aneuploidy. It may be possible to identify cases with favorable prognosis in a group of low grade carcinomas on the grounds of diploid DNA content and low values of these markers.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1574251     DOI: 10.1159/000227029

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  4 in total

1.  Argyrophilic Nucleolar Organizer Regions of Breast Tumors: Assessment of Aspirated Cytological Materials.

Authors: 
Journal:  Breast Cancer       Date:  1996-12-20       Impact factor: 4.239

2.  Demonstration of silver-stained nucleolar organizer region associated proteins (AgNORs) after wet autoclave pretreatment in breast carcinoma: correlation to tumor stage and long-term survival.

Authors:  D Ofner; B Bier; S Heinrichs; M Berghorn; M Dünser; H A Hagemann; D Langer; W Böcker; K W Schmid
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  Luminal A and luminal B (HER2 negative) subtypes of breast cancer consist of a mixture of tumors with different genotype.

Authors:  Masumi Yanagawa; Kenzo Ikemot; Shigeto Kawauchi; Tomoko Furuya; Shigeru Yamamoto; Masaaki Oka; Atunori Oga; Yukiko Nagashima; Kohsuke Sasaki
Journal:  BMC Res Notes       Date:  2012-07-25

4.  Difference between Luminal A and Luminal B Subtypes According to Ki-67, Tumor Size, and Progesterone Receptor Negativity Providing Prognostic Information.

Authors:  Zorka Inic; Milan Zegarac; Momcilo Inic; Ivan Markovic; Zoran Kozomara; Igor Djurisic; Ivana Inic; Gordana Pupic; Snezana Jancic
Journal:  Clin Med Insights Oncol       Date:  2014-09-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.